✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹432 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
432 Cr
PE
PE
-
Prom Holding
Prom Holding
51.12 %
ROE (%)
ROE (%)
17.29
ROCE (%)
ROCE (%)
-59.31
Div Yield (%)
Div Yield (%)
-
Sales
Sales
110 Cr
OPM (%)
OPM (%)
-8.40 %
Debt to Equity
Debt to Equity
-2.77
About
SS Organics Ltd is a pharmaceutical company involved in the manufacture and marketing of bulk … Read more
Low
30
52W Range
High
134
  • Oxygenta Pharma
  • Lyka Labs
  • Brooks Laboratories

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Oxygenta Pharmaceutical Ltd. Business

SS Organics Ltd is a pharmaceutical company that focuses on producing and marketing bulk drugs and intermediates, specializing in new-generation medications such as quinolones, antiasthmatics, antiulcerants, and anti-inflammatories.

Oxygenta Pharma major competitors are Brooks Laboratories, Lyka Labs, Zenotech Laboratorie, Fredun Pharma, Chandan Healthcare, Valiant Laboratories, SMS Lifesciences.
Market Cap of Oxygenta Pharma is ₹432 Crs.
While the median market cap of its peers are ₹405 Crs.

Oxygenta Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Oxygenta Pharma is 1.85 and is ranked 8 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material